Tango Therapeutics Market Sentiment

SPY762.27−1.23%QQQ708.95−2.62%BTC/USD81,658.87−0.57%DIA518.53−0.49%GLD381.50−0.32%TLT80.05+0.09%

Premium

Tango Therapeutics Inc

TNGXNASDAQ

Trade with Public

$22.04

-0.66-2.91%

Last update: Oct 16, 4:00 PM

$23.00

0.301.32%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Tango Therapeutics Market Sentiment

Market sentiment signals for Tango Therapeutics (TNGX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 26.7% short float

Options Flow▼ 2.24 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

17 analysts

Options Flow (P/C)

2.24

More puts — Bearish

421 calls · 942 puts

Avg Consensus PT

$37

+67.9%

Highest Price Target

$69

+213.1%

Leerink Partners

Lowest Price Target

$12

-45.6%

Guggenheim

Short Interest

26.7%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 16, 2026	William Blair	Alethia Young—	—	—	Initiate	Outperform
Aug 18, 2026	HC Wainwright & Co.	Robert Burns—	+208.5%	$66 → $68	Maintained	Buy
Aug 12, 2026	Guggenheim	Michael Schmidt—	+58.8%	$32 → $35	Maintained	Buy
Jul 17, 2026	Mizuho	Joseph Catanzaro—	+81.5%	$36 → $40	Maintained	Outperform
Jul 15, 2026	JP Morgan	Brian Cheng—	+108.7%	$46	Initiate	Overweight
Jun 29, 2026	Canaccord Genuity	John Newman—	+108.7%	$42 → $46	Maintained	Buy
Jun 26, 2026	Jefferies	Maury Raycroft—	+172.2%	$27 → $60	Upgrade	Hold→Buy
Jun 11, 2026	Canaccord Genuity	John Newman—	+90.6%	$42 → $42	Maintained	Buy
Jun 9, 2026	HC Wainwright & Co.	Robert Burns—	+199.5%	$27 → $66	Maintained	Buy
Jun 9, 2026	Canaccord Genuity	John Newman—	+90.6%	$30 → $42	Maintained	Buy
Jun 8, 2026	Leerink Partners	Andrew Berens—	+213.1%	$55 → $69	Maintained	Outperform
May 15, 2026	Piper Sandler	Kelsey Goodwin—	+8.9%	$16 → $24	Downgrade	Overweight→Neutral
May 15, 2026	Mizuho	Joseph Catanzaro—	+36.1%	$20 → $30	Maintained	Outperform
May 14, 2026	Jefferies	Maury Raycroft—	+22.5%	$18 → $27	Downgrade	Buy→Hold
May 14, 2026	Leerink Partners	Andrew Berens—	+149.5%	$28 → $55	Maintained	Outperform
May 14, 2026	Wedbush	Robert Driscoll—	+49.7%	$19 → $33	Maintained	Outperform
Apr 27, 2026	Stifel	Laura Prendergast—	+81.5%	$24 → $40	Maintained	Buy
Apr 2, 2026	Canaccord Genuity	John Newman—	+36.1%	$30	Initiate	Buy
Mar 11, 2026	Mizuho	Joseph Catanzaro—	-9.3%	$19 → $20	Maintained	Outperform
Mar 9, 2026	Stifel	Laura Prendergast—	+8.9%	$15 → $24	Maintained	Buy
Mar 6, 2026	Wedbush	Robert Driscoll—	-13.8%	$15 → $19	Maintained	Outperform
Mar 6, 2026	Guggenheim	Michael Schmidt—	-9.3%	$18 → $20	Maintained	Buy
Mar 6, 2026	HC Wainwright & Co.	Robert Burns—	+22.5%	$13 → $27	Maintained	Buy
Feb 23, 2026	Mizuho	Joseph Catanzaro—	-13.8%	$19	Initiate	Outperform
Feb 6, 2026	Guggenheim	Michael Schmidt—	-18.3%	$12 → $18	Maintained	Buy